Activity of the antiarrhythmic drug amiodarone against Leishmania (L.) infantum: an in vitro and in vivo approach View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-10-25

AUTHORS

Erika G. Pinto, Andre G. Tempone

ABSTRACT

BackgroundConsidering the high toxicity and limited therapies available for treating visceral leishmaniasis (VL), the drug repositioning approach represents a faster way to deliver new therapies to the market.MethodsIn this study, we described for the first time the activity of a potent antiarrhythmic, amiodarone (AMD), against L. (L.) infantum and its in vitro and in vivo activity.ResultsThe evaluation against promastigotes has shown that amiodarone presents leishmanicidal effect against the extracellular form, with an IC50 value of 10 μM. The activity was even greater against amastigotes in comparison with promastigotes with an IC50 value of 0.5 μM. The selectivity index in relation to the intracellular form demonstrated that the antiparasitic activity was approximately 56 times higher than its toxicity to mammalian cells. Investigation of the in vivo AMD activity in the L. infantum-infected hamster model showed that 51 days after the initial infection, amiodarone was unable to reduce the parasite burden in the spleen and liver when treated for 10 consecutive days, intraperitoneally, at 50 mg/kg/day, as determined by qPCR. Although not statistically significant, AMD was able to reduce the parasite burden by 20% in the liver when treated for 10 consecutive days, orally, at 100 mg/kg/day; no reduction in the spleen was found by qPCR.ConclusionsOur findings may help further drug design studies seeking new AMD derivatives that may provide new candidates with an in vitro selectivity close to or even greater than that observed in the prototype delivering effectiveness in the experimental model of VL. More... »

PAGES

29

References to SciGraph publications

  • 2006-11. Innovative lead discovery strategies for tropical diseases in NATURE REVIEWS DRUG DISCOVERY
  • 2008-12. Hepatotoxicity after intravenous amiodarone in AGING CLINICAL AND EXPERIMENTAL RESEARCH
  • 2006-12. Drug discovery and development for neglected parasitic diseases in NATURE CHEMICAL BIOLOGY
  • 2003-11. Virtual drug discovery and development for neglected diseases through public–private partnerships in NATURE REVIEWS DRUG DISCOVERY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s40409-018-0166-7

    DOI

    http://dx.doi.org/10.1186/s40409-018-0166-7

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1107854040

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30386379


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0608", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Zoology", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, UK", 
              "id": "http://www.grid.ac/institutes/grid.497856.1", 
              "name": [
                "Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, UK"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pinto", 
            "givenName": "Erika G.", 
            "id": "sg:person.01105270210.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105270210.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8\u00b0, Andar. Cerqueira C\u00e9sar, CEP 01246-902, S\u00e3o Paulo, SP, Brazil", 
              "id": "http://www.grid.ac/institutes/grid.417672.1", 
              "name": [
                "Centre for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8\u00b0, Andar. Cerqueira C\u00e9sar, CEP 01246-902, S\u00e3o Paulo, SP, Brazil"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Tempone", 
            "givenName": "Andre G.", 
            "id": "sg:person.01044254247.31", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044254247.31"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nchembio837", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010346142", 
              "https://doi.org/10.1038/nchembio837"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf03324889", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032248588", 
              "https://doi.org/10.1007/bf03324889"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd1230", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036759578", 
              "https://doi.org/10.1038/nrd1230"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd2144", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012936695", 
              "https://doi.org/10.1038/nrd2144"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-10-25", 
        "datePublishedReg": "2018-10-25", 
        "description": "BackgroundConsidering the high toxicity and limited therapies available for treating visceral leishmaniasis (VL), the drug repositioning approach represents a faster way to deliver new therapies to the market.MethodsIn this study, we described for the first time the activity of a potent antiarrhythmic, amiodarone (AMD), against L. (L.) infantum and its in vitro and in vivo activity.ResultsThe evaluation against promastigotes has shown that amiodarone presents leishmanicidal effect against the extracellular form, with an IC50 value of 10\u00a0\u03bcM. The activity was even greater against amastigotes in comparison with promastigotes with an IC50 value of 0.5\u00a0\u03bcM. The selectivity index in relation to the intracellular form demonstrated that the antiparasitic activity was approximately 56 times higher than its toxicity to mammalian cells. Investigation of the in vivo AMD activity in the L. infantum-infected hamster model showed that 51\u00a0days after the initial infection, amiodarone was unable to reduce the parasite burden in the spleen and liver when treated for 10 consecutive days, intraperitoneally, at 50\u00a0mg/kg/day, as determined by qPCR. Although not statistically significant, AMD was able to reduce the parasite burden by 20% in the liver when treated for 10 consecutive days, orally, at 100\u00a0mg/kg/day; no reduction in the spleen was found by qPCR.ConclusionsOur findings may help further drug design studies seeking new AMD derivatives that may provide new candidates with an in vitro selectivity close to or even greater than that observed in the prototype delivering effectiveness in the experimental model of VL.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s40409-018-0166-7", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.4899615", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1357529", 
            "issn": [
              "1678-9180", 
              "1678-9199"
            ], 
            "name": "Journal of Venomous Animals and Toxins including Tropical Diseases", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "24"
          }
        ], 
        "keywords": [
          "visceral leishmaniasis", 
          "parasite burden", 
          "consecutive days", 
          "antiarrhythmic drug amiodarone", 
          "potent antiarrhythmic", 
          "IC50 values", 
          "limited therapies", 
          "hamster model", 
          "new therapies", 
          "amiodarone", 
          "leishmanicidal effect", 
          "AMD activities", 
          "initial infection", 
          "L. infantum", 
          "Leishmania infantum", 
          "ConclusionsOur findings", 
          "drug amiodarone", 
          "experimental model", 
          "drug repositioning approach", 
          "vivo activity", 
          "selectivity index", 
          "vivo approaches", 
          "further drug design studies", 
          "therapy", 
          "antiparasitic activity", 
          "spleen", 
          "intracellular form", 
          "liver", 
          "infantum", 
          "days", 
          "promastigotes", 
          "burden", 
          "repositioning approach", 
          "toxicity", 
          "qPCR", 
          "extracellular form", 
          "antiarrhythmics", 
          "activity", 
          "infection", 
          "leishmaniasis", 
          "MethodsIn", 
          "amastigotes", 
          "new candidates", 
          "BackgroundConsidering", 
          "high toxicity", 
          "drug design studies", 
          "study", 
          "cells", 
          "mammalian cells", 
          "findings", 
          "index", 
          "design study", 
          "evaluation", 
          "time", 
          "reduction", 
          "effect", 
          "first time", 
          "candidates", 
          "values", 
          "form", 
          "effectiveness", 
          "investigation", 
          "comparison", 
          "model", 
          "approach", 
          "relation", 
          "derivatives", 
          "selectivity", 
          "way", 
          "fast way", 
          "prototype", 
          "market"
        ], 
        "name": "Activity of the antiarrhythmic drug amiodarone against Leishmania (L.) infantum: an in vitro and in vivo approach", 
        "pagination": "29", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1107854040"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s40409-018-0166-7"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30386379"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s40409-018-0166-7", 
          "https://app.dimensions.ai/details/publication/pub.1107854040"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_771.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s40409-018-0166-7"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40409-018-0166-7'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40409-018-0166-7'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40409-018-0166-7'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40409-018-0166-7'


     

    This table displays all metadata directly associated to this object as RDF triples.

    161 TRIPLES      21 PREDICATES      101 URIs      89 LITERALS      7 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s40409-018-0166-7 schema:about anzsrc-for:06
    2 anzsrc-for:0608
    3 schema:author N96e3c953eaad46d5a40a5dae09d764a7
    4 schema:citation sg:pub.10.1007/bf03324889
    5 sg:pub.10.1038/nchembio837
    6 sg:pub.10.1038/nrd1230
    7 sg:pub.10.1038/nrd2144
    8 schema:datePublished 2018-10-25
    9 schema:datePublishedReg 2018-10-25
    10 schema:description BackgroundConsidering the high toxicity and limited therapies available for treating visceral leishmaniasis (VL), the drug repositioning approach represents a faster way to deliver new therapies to the market.MethodsIn this study, we described for the first time the activity of a potent antiarrhythmic, amiodarone (AMD), against L. (L.) infantum and its in vitro and in vivo activity.ResultsThe evaluation against promastigotes has shown that amiodarone presents leishmanicidal effect against the extracellular form, with an IC50 value of 10 μM. The activity was even greater against amastigotes in comparison with promastigotes with an IC50 value of 0.5 μM. The selectivity index in relation to the intracellular form demonstrated that the antiparasitic activity was approximately 56 times higher than its toxicity to mammalian cells. Investigation of the in vivo AMD activity in the L. infantum-infected hamster model showed that 51 days after the initial infection, amiodarone was unable to reduce the parasite burden in the spleen and liver when treated for 10 consecutive days, intraperitoneally, at 50 mg/kg/day, as determined by qPCR. Although not statistically significant, AMD was able to reduce the parasite burden by 20% in the liver when treated for 10 consecutive days, orally, at 100 mg/kg/day; no reduction in the spleen was found by qPCR.ConclusionsOur findings may help further drug design studies seeking new AMD derivatives that may provide new candidates with an in vitro selectivity close to or even greater than that observed in the prototype delivering effectiveness in the experimental model of VL.
    11 schema:genre article
    12 schema:isAccessibleForFree true
    13 schema:isPartOf Nba5f99aa20db4958bae368f5a75f53d2
    14 Nc5f90f1f5b6744e1adec9b1f163bca07
    15 sg:journal.1357529
    16 schema:keywords AMD activities
    17 BackgroundConsidering
    18 ConclusionsOur findings
    19 IC50 values
    20 L. infantum
    21 Leishmania infantum
    22 MethodsIn
    23 activity
    24 amastigotes
    25 amiodarone
    26 antiarrhythmic drug amiodarone
    27 antiarrhythmics
    28 antiparasitic activity
    29 approach
    30 burden
    31 candidates
    32 cells
    33 comparison
    34 consecutive days
    35 days
    36 derivatives
    37 design study
    38 drug amiodarone
    39 drug design studies
    40 drug repositioning approach
    41 effect
    42 effectiveness
    43 evaluation
    44 experimental model
    45 extracellular form
    46 fast way
    47 findings
    48 first time
    49 form
    50 further drug design studies
    51 hamster model
    52 high toxicity
    53 index
    54 infantum
    55 infection
    56 initial infection
    57 intracellular form
    58 investigation
    59 leishmaniasis
    60 leishmanicidal effect
    61 limited therapies
    62 liver
    63 mammalian cells
    64 market
    65 model
    66 new candidates
    67 new therapies
    68 parasite burden
    69 potent antiarrhythmic
    70 promastigotes
    71 prototype
    72 qPCR
    73 reduction
    74 relation
    75 repositioning approach
    76 selectivity
    77 selectivity index
    78 spleen
    79 study
    80 therapy
    81 time
    82 toxicity
    83 values
    84 visceral leishmaniasis
    85 vivo activity
    86 vivo approaches
    87 way
    88 schema:name Activity of the antiarrhythmic drug amiodarone against Leishmania (L.) infantum: an in vitro and in vivo approach
    89 schema:pagination 29
    90 schema:productId N281a30d019eb4872bdc6c634ce07266f
    91 N6e731edf64f24f3d9e48b199251bd838
    92 N81c030bc340d402992256a0c9f579981
    93 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107854040
    94 https://doi.org/10.1186/s40409-018-0166-7
    95 schema:sdDatePublished 2022-12-01T06:37
    96 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    97 schema:sdPublisher N991712d7bc9344ffa63b713923e60279
    98 schema:url https://doi.org/10.1186/s40409-018-0166-7
    99 sgo:license sg:explorer/license/
    100 sgo:sdDataset articles
    101 rdf:type schema:ScholarlyArticle
    102 N281a30d019eb4872bdc6c634ce07266f schema:name pubmed_id
    103 schema:value 30386379
    104 rdf:type schema:PropertyValue
    105 N6e731edf64f24f3d9e48b199251bd838 schema:name doi
    106 schema:value 10.1186/s40409-018-0166-7
    107 rdf:type schema:PropertyValue
    108 N81c030bc340d402992256a0c9f579981 schema:name dimensions_id
    109 schema:value pub.1107854040
    110 rdf:type schema:PropertyValue
    111 N96e3c953eaad46d5a40a5dae09d764a7 rdf:first sg:person.01105270210.19
    112 rdf:rest Naa6b0b42789f4a33a556d05a6e8d3c4c
    113 N991712d7bc9344ffa63b713923e60279 schema:name Springer Nature - SN SciGraph project
    114 rdf:type schema:Organization
    115 Naa6b0b42789f4a33a556d05a6e8d3c4c rdf:first sg:person.01044254247.31
    116 rdf:rest rdf:nil
    117 Nba5f99aa20db4958bae368f5a75f53d2 schema:issueNumber 1
    118 rdf:type schema:PublicationIssue
    119 Nc5f90f1f5b6744e1adec9b1f163bca07 schema:volumeNumber 24
    120 rdf:type schema:PublicationVolume
    121 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    122 schema:name Biological Sciences
    123 rdf:type schema:DefinedTerm
    124 anzsrc-for:0608 schema:inDefinedTermSet anzsrc-for:
    125 schema:name Zoology
    126 rdf:type schema:DefinedTerm
    127 sg:grant.4899615 http://pending.schema.org/fundedItem sg:pub.10.1186/s40409-018-0166-7
    128 rdf:type schema:MonetaryGrant
    129 sg:journal.1357529 schema:issn 1678-9180
    130 1678-9199
    131 schema:name Journal of Venomous Animals and Toxins including Tropical Diseases
    132 schema:publisher Springer Nature
    133 rdf:type schema:Periodical
    134 sg:person.01044254247.31 schema:affiliation grid-institutes:grid.417672.1
    135 schema:familyName Tempone
    136 schema:givenName Andre G.
    137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044254247.31
    138 rdf:type schema:Person
    139 sg:person.01105270210.19 schema:affiliation grid-institutes:grid.497856.1
    140 schema:familyName Pinto
    141 schema:givenName Erika G.
    142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105270210.19
    143 rdf:type schema:Person
    144 sg:pub.10.1007/bf03324889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032248588
    145 https://doi.org/10.1007/bf03324889
    146 rdf:type schema:CreativeWork
    147 sg:pub.10.1038/nchembio837 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010346142
    148 https://doi.org/10.1038/nchembio837
    149 rdf:type schema:CreativeWork
    150 sg:pub.10.1038/nrd1230 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036759578
    151 https://doi.org/10.1038/nrd1230
    152 rdf:type schema:CreativeWork
    153 sg:pub.10.1038/nrd2144 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012936695
    154 https://doi.org/10.1038/nrd2144
    155 rdf:type schema:CreativeWork
    156 grid-institutes:grid.417672.1 schema:alternateName Centre for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8°, Andar. Cerqueira César, CEP 01246-902, São Paulo, SP, Brazil
    157 schema:name Centre for Parasitology and Mycology, Instituto Adolfo Lutz, Avenida Dr. Arnaldo, 351, 8°, Andar. Cerqueira César, CEP 01246-902, São Paulo, SP, Brazil
    158 rdf:type schema:Organization
    159 grid-institutes:grid.497856.1 schema:alternateName Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, UK
    160 schema:name Wellcome Centre for Anti-Infectives Research, School of Life Sciences, University of Dundee, Dundee, UK
    161 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...